Covered recipient · General Payments record
WILLIAM S BOYD
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,427.56
- Reported across 89 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $291.28 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $73.59 | 4 |
| Novo Nordisk AS | $63.60 | 4 |
| ABBVIE INC. | $32.87 | 2 |
| Exact Sciences Corporation | $30.50 | 2 |
| Mylan Specialty L.P. | $25.07 | 1 |
| PFIZER INC. | $18.19 | 1 |
| GlaxoSmithKline, LLC. | $16.56 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.35 | 1 |
| Astellas Pharma US Inc | $14.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.37 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809738 | CMS |
| ABBVIE INC. | $18.50 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809740 | CMS |
| Astellas Pharma US Inc | $14.55 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139539308 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.35 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118011821 | CMS |
| Exact Sciences Corporation | $15.50 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114552984 | CMS |
| Exact Sciences Corporation | $15.00 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114552988 | CMS |
| GlaxoSmithKline, LLC. | $16.56 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116030059 | CMS |
| Lilly USA, LLC | $16.23 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135990788 | CMS |
| Lilly USA, LLC | $19.97 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135990790 | CMS |
| Lilly USA, LLC | $17.29 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135974732 | CMS |
| Lilly USA, LLC | $20.10 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135974730 | CMS |
| Mylan Specialty L.P. | $25.07 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147344672 | CMS |
| Novo Nordisk Inc | $13.38 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100384085 | CMS |
| Novo Nordisk Inc | $16.91 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100531859 | CMS |
| Novo Nordisk Inc | $16.00 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100512103 | CMS |
| Novo Nordisk Inc | $17.31 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100236368 | CMS |
| PFIZER INC. | $18.19 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131876893 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.